Experience: high quality expertise in clinical development
The average experience in clinical development of the company’s employees is 15 years, guaranteeing a very high level of expertise.
ATLANSTAT implements its services in a constant respect of the recommendations and regulations in force of the EMA (European Medicines Agency) and the FDA (Food and Drug Administration) and participates actively in the submissions of health products in an international context.
In parallel to the private sector, ATLANSTAT has a particular experience of studies and institutional context: CHUs, UNICANCER, INSERM…
Thanks to the experience of ATLANSTAT’s staff, clients trust us to conduct analyses as an independent statistical center.
This allows us to produce the statistical results of interim analyses before the end of the study, to participate in Data Monitoring Committees in direct relation with the experts without the sponsor being informed of the detailed statistical results.
A constant innovation
The Contract Research Organization ATLANSTAT has developed partnerships with public organizations in order to propose innovative statistical offers.
It was supported by BPI France in a project to develop a randomization tool for adaptive trials.
It has recently developed, in partnership with the Nantes University Hospital, a project proposing an innovative statistical methodology making it possible to precisely identify a population of patients who do not respond to a treatment even though the criterion indentifying this population has not yet been measured… This project is part of the development of personalized medicine.
ATLANSTAT is a member of the AFCRO (French Association of CROs) which was born from the common reflection of service and consulting companies in pharmaceutical and medical development for Health Products. It allows in particular a regulatory follow-up and monitoring communicated to all its members.
ATLANSTAT is a member of the Atlanpole Biotherapies competitiveness cluster. This cluster federates the skills of laboratories, platforms and companies to provide a complete public-private offer on the biomedicine value chain from target discovery to clinical evaluation.
ATLANSTAT has joined the UN Global Compact, guaranteeing its commitment to Corporate Social Responsibility (CSR).